Showing results (2251-2260 of 5,227) with videos related to
Sort By:
Pageof 523
Antiviral Research|October 1, 1987
Tolerance and nasal histopathologic effects of long-term, low-dose intranasal recombinant interferon alpha-2A (Roferon-A)F G Hayden, S E Mills, D J Innes, et al.Antiviral Research|October 1, 1985
Exquisite specificity of adoptive immunization in arenavirus-infected miceK W McIntyre, J F Bukowski, R M WelshAntiviral Research|July 27, 2021
Baseline serum hepatitis B core antibody level predicts HBeAg seroconversion in patients with HBeAg-positive chronic hepatitis B after antiviral treatmentXiang-An Zhao, Jian Wang, Jiacheng Liu, et al.Antiviral Research|December 12, 2022
Discovery of lead natural products for developing pan-SARS-CoV-2 therapeuticsJimena Pérez-Vargas, Tirosh Shapira, Andrea D Olmstead, et al.Antiviral Research|November 28, 2020
Metabolic regulation of the HBV-specific T cell functionValeria Barili, Carolina Boni, Marzia Rossi, et al.Antiviral Research|February 22, 2020
The direct and indirect consequences of cytomegalovirus infection and potential benefits of vaccinationPaul GriffithsAntiviral Research|February 22, 2020
Sex-determining region Y box 4 (SOX4) suppresses Hepatitis B virus replication by inhibiting hepatocyte nuclear factor 4α expressionShu Shi, Mingchen Liu, Jingyuan Xi, et al.Antiviral Research|July 15, 2021
Preclinical evaluation of Imatinib does not support its use as an antiviral drug against SARS-CoV-2Franck Touret, Jean-Sélim Driouich, Maxime Cochin, et al.Antiviral Research|July 25, 2021
Identification and evaluation of potential SARS-CoV-2 antiviral agents targeting mRNA cap guanine N7-MethyltransferaseRenata Kasprzyk, Tomasz J Spiewla, Miroslaw Smietanski, et al.Antiviral Research|May 23, 2022
Animal models for studying coronavirus infections and developing antiviral agents and vaccinesQisheng Lin, Chunni Lu, Yuqi Hong, et al.Pageof 523